Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies-Reference-Cited by-同舟云学术

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

Published:2009-08-10 Issue:1 Volume:8 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Bonnet Maryline,van den Broek Ingrid,van Herp Michel,Urrutia Pedro Pablo Palma,van Overmeir Chantal,Kyomuhendo Juliet,Ndosimao Célestin Nsibu,Ashley Elizabeth,Guthmann Jean-Paul

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/1475-2875-8-192.pdf

Reference26 articles.

1. World Health Organization: World malaria report 2008. Country profile by WHO region. WHO Geneva. 10.1111/j.1365-3156.2006.01710.x.

2. Swarthout TB, Broek van den IV, Kayembe G, Pota H, Roper C: Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. TMIH. 2006, 11: 1503-1511. 10.1111/j.1365-3156.2008.02150.x.

3. Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR: dhfr and dhps genotype and sulfadoxine-pyrimethaminetreatment failure in children with falciparum malaria in the Democratic Republic of Congo. Tropical Medicine and International Health. 2008, 13: 1384-1391. 10.1016/S0140-6736(98)24022-0.

4. Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV: Molecular assays for surveillance of antifolate-resistant malaria. Lancet. 1998, 351: 1629-1630. 10.1016/j.meegid.2004.04.002.

5. Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U: Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. Infect Genet Evol. 2004, 4: 321-327. 10.1016/j.meegid.2004.04.002.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemogenomic Profiling of a Plasmodium falciparum Transposon Mutant Library Reveals Shared Effects of Dihydroartemisinin and Bortezomib on Lipid Metabolism and Exported Proteins;Microbiology Spectrum;2023-06-15

2. Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data;BMC Medicine;2022-03-07

3. The Impact of Artesunate-Amodiaquine on Schistosoma mansoni Infection among Children Infected by Plasmodium in Rural Area of Lemfu, Kongo Central, Democratic Republic of the Congo;BioMed Research International;2018-07-16

4. Increasing the Strength and Production of Artemisinin and Its Derivatives;Molecules;2018-01-03

5. Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo;PLOS ONE;2016-06-09